Chung Wu Investment Group »

Taysha Gene Therapies shares owned by Chung Wu Investment Group

Quarter-by-quarter ownership of Taysha Gene Therapies (TSHA) shares owned by Chung Wu Investment Group from 13F filings

Historical chart of Chung Wu Investment Group investment in Taysha Gene Therapies

Tip: Access up to 7 years of quarterly data

All positions including Taysha Gene Therapies held by Chung Wu Investment Group consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Taysha Gene Therapies by Chung Wu Investment Group

Quarter filed Position value Share count Share price at filing
2025-12-31 $22k 4.0k 5.50

More positions owned by Chung Wu Investment Group

Ishares Tr Core S&p500 Etf Core S&p500 Etf (IVV)
Microsoft Corporation (MSFT)
Spdr Dow Jones Industrial Average Etf Trust Ut Ser 1 (DIA)
Neos S&p 500 High Income Etf Neos S&p 500 Hi (SPYI)
Neos Nasdaq 100 High Income Etf Nasdaq 100 High (QQQI)
Apple (AAPL)
JPMorgan Chase & Co. (JPM)
Eaton Vance Enhanced Equity Incm. Fd. II (EOS)
NVIDIA Corporation (NVDA)
Spdr S&p 500 Etf Tr Unit (SPY)
Micron Technology (MU)
Antero Midstream Corp antero midstream (AM)
Abbvie (ABBV)
Goldman Sachs (GS)
Exxon Mobil Corporation (XOM)

View all positions for Chung Wu Investment Group

Top funds holding Taysha Gene Therapies

RA Capital Management
venBio Select Advisor
BlackRock
Rtw Investments
FMR
Vestal Point Capital
Goldman Sachs Group
Vanguard Group
State Street Corporation
Siren
Octagon Capital Advisors
Polar Capital Holdings
Barclays
Geode Capital Management
Millennium Management

View all funds holding Taysha Gene Therapies